Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07097922
NA

Compare the Clinical Efficacy of 3% Diquafosol and 0.1% Hyaluronic Acid in Patients With Dry Eye After LASIK

Sponsor: He Eye Hospital

View on ClinicalTrials.gov

Summary

The prevalence of refractive ametropia is rising year by year. Refractive surgery has become the main approach for adults to correct refractive ametropia, and postoperative complications have aroused extensive attention from clinicians. Dry eye after refractive surgery is one of the postoperative complications, which is an important cause of affecting the postoperative visual quality and satisfaction of patients. It was reported that 3% diquafosol (DQS) and 0.1% hyaluronic acid (HA) can relieve dry eye symptoms. This study aims to compare the efficacy of 3% DQS and 0.1% HA in treating dry eye after LASIK

Key Details

Gender

All

Age Range

18 Years - 40 Years

Study Type

INTERVENTIONAL

Enrollment

140

Start Date

2025-08-01

Completion Date

2026-05-01

Last Updated

2025-08-01

Healthy Volunteers

No

Conditions

Interventions

DRUG

3% Diquafosol Sodium Eye Drops

3% Diquafosol Sodium Eye Drops were instilled into the inferior conjunctival vault of both eyes

DRUG

0.1% hyaluronic acid

0.1% sodium hyaluronate eye drops were instillation into the inferior conjunctival vault of both eyes